Effectiveness and Cost of Olanzapine and Haloperidol in the Treatment of Schizophrenia: A
Randomized Controlled Trial. (Rosenheck R et al. JAMA. 2003 Nov 26;290(20):2693-702.)
A Randomized Trial of Letrozole in Postmenopausal Women After Five Years of Tamoxifen Therapy
for Early-Stage Breast cancer. (Goss PE et al. N Engl J Med. 2003 Nov 6;349(19):1793-802.)
Childhood Cardiovascular Risk Factors and Carotid Vascular Changes in Adulthood: The
Bogalusa Heart Study. (Li S et al. JAMA. 2003 Nov 5;290(17):2271-6.)
The Effects of Parathyroid Hormone and Alendronate Alone or in Combination in Postmenopausal
Osteoporosis. (Black DM et al. N Engl J Med. 2003 Sep 20 [Epub ahead of print].)
The Effects of Parathyroid Hormone, Alendronate, or Both in Men with Osteoporosis. (Finkelstein
JS et al. N Engl J Med. 2003 Sep 20 [Epub ahead of print].)
Influence of Estrogen Plus Progestin on Breast Cancer and Mammography in Healthy Postmenopausal
Women (Chlebowski RT et al. JAMA. 2003 Jun 25;289(24):3243-53.)
Study of Heart Disease Patients Treated for Depression and Low Social Support Finds No Survival
Benefit but Significant Improvement in Depression and Social Functioning (NHLBI, June 17, 2003)
Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and
South America (Lalezari JP et al. N Engl J Med 2003 May 29;348(22):2175-85)
Efficacy of Enfuvirtide in Patients Infected with Drug-Resistant HIV-1 in Europe and
Australia (Lazzarin A et al. N Engl J Med 2003 May 29;348(22):2186-95)
Television Watching and Other Sedentary Behaviors in Relation to Risk of Obesity
and Type 2 Diabetes Mellitus in Women (Hu FB et al. JAMA. 2003;289:1785-1791)
Important Interim Results from a Phase III, Randomized, Double-Blind Comparison of Three
Protease-Inhibitor-Sparing Regimens for the Initial Treatment of HIV Infection
(AACTG Protocol A5095) (NIAID, March 13, 2003)
Total hip replacement due to osteoarthritis: the importance of age, obesity, and other modifiable
risk factors. (Karlson EW et al. Am J Med 2003 Feb 1;114(2):93-98)
Anger Expression and Risk of Stroke and Coronary Heart Disease Among Male Health Professionals
(Eng PM et al. Psychosom Med 2003 Jan-Feb;65(1):100-10.)
A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis. (Miller DH et al.; International
Natalizumab Multiple Sclerosis Trial Group. N Engl J Med 2003 Jan 2;348(1):15-23)